A Prospective, Open-Label, Randomized, Controlled Post-Market Clinical Trial Investigating the Safety and Effectiveness of Human Amnion Membrane (AM) in a Cohort of Patients with Loss of Full Thickness Skin Graft Following Reconstruction of a Cutaneous Nasal Defect Secondary to Skin Cancer Resection.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2024
This article has no abstract
Epistemonikos ID: 3b10c3f4ff31b078317a0779ba1d7b969ca27b1c
First added on: Mar 18, 2025